- Home
- GSRT vs LUNG Comparison
GSRT vs LUNG Comparison
Compare GSRT & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSRT
- LUNG
- Stock Information
- Founded
- GSRT 2023
- LUNG 1995
- Country
- GSRT United States
- LUNG United States
- Employees
- GSRT N/A
- LUNG N/A
- Industry
- GSRT
- LUNG Industrial Specialties
- Sector
- GSRT
- LUNG Health Care
- Exchange
- GSRT Nasdaq
- LUNG Nasdaq
- Market Cap
- GSRT 316.5M
- LUNG 124.0M
- IPO Year
- GSRT 2024
- LUNG 2020
- Fundamental
- Price
- GSRT $10.80
- LUNG $2.78
- Analyst Decision
- GSRT
- LUNG Buy
- Analyst Count
- GSRT 0
- LUNG 6
- Target Price
- GSRT N/A
- LUNG $11.53
- AVG Volume (30 Days)
- GSRT 1.3M
- LUNG 311.3K
- Earning Date
- GSRT 01-01-0001
- LUNG 07-30-2025
- Dividend Yield
- GSRT N/A
- LUNG N/A
- EPS Growth
- GSRT N/A
- LUNG N/A
- EPS
- GSRT 0.14
- LUNG N/A
- Revenue
- GSRT N/A
- LUNG $87,473,000.00
- Revenue This Year
- GSRT N/A
- LUNG $18.02
- Revenue Next Year
- GSRT N/A
- LUNG $18.17
- P/E Ratio
- GSRT $76.13
- LUNG N/A
- Revenue Growth
- GSRT N/A
- LUNG 19.84
- 52 Week Low
- GSRT $9.86
- LUNG $2.50
- 52 Week High
- GSRT $11.49
- LUNG $9.37
- Technical
- Relative Strength Index (RSI)
- GSRT N/A
- LUNG 41.83
- Support Level
- GSRT N/A
- LUNG $2.52
- Resistance Level
- GSRT N/A
- LUNG $2.84
- Average True Range (ATR)
- GSRT 0.00
- LUNG 0.16
- MACD
- GSRT 0.00
- LUNG 0.04
- Stochastic Oscillator
- GSRT 0.00
- LUNG 46.36
About GSRT GSR III Acquisition Corp. Ordinary Shares
GSR III Acquisition Corp is a blank check company.
About LUNG Pulmonx Corporation
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.